STAAR Surgical Revenue 2010-2024 | STAA

STAAR Surgical revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
STAAR Surgical Annual Revenue
(Millions of US $)
2024 $314
2023 $322
2022 $284
2021 $230
2020 $163
2019 $150
2018 $124
2017 $91
2016 $82
2015 $77
2014 $75
2013 $72
2012 $64
2011 $63
2010 $55
2009 $51
STAAR Surgical Quarterly Revenue
(Millions of US $)
2024-12-31 $49
2024-09-30 $89
2024-06-30 $99
2024-03-31 $77
2023-12-31 $76
2023-09-30 $80
2023-06-30 $92
2023-03-31 $74
2022-12-31 $64
2022-09-30 $76
2022-06-30 $81
2022-03-31 $63
2021-12-31 $59
2021-09-30 $58
2021-06-30 $62
2021-03-31 $51
2020-12-31 $46
2020-09-30 $47
2020-06-30 $35
2020-03-31 $35
2019-12-31 $39
2019-09-30 $39
2019-06-30 $40
2019-03-31 $33
2018-12-31 $31
2018-09-30 $32
2018-06-30 $34
2018-03-31 $27
2017-12-31 $25
2017-09-30 $23
2017-06-30 $22
2017-03-31 $20
2016-12-31 $22
2016-09-30 $20
2016-06-30 $21
2016-03-31 $19
2015-12-31 $21
2015-09-30 $19
2015-06-30 $19
2015-03-31 $19
2014-12-31 $17
2014-09-30 $18
2014-06-30 $20
2014-03-31 $20
2013-12-31 $19
2013-09-30 $17
2013-06-30 $18
2013-03-31 $18
2012-12-31 $16
2012-09-30 $16
2012-06-30 $16
2012-03-31 $16
2011-12-31 $16
2011-09-30 $15
2011-06-30 $16
2011-03-31 $15
2010-12-31 $14
2010-09-30 $13
2010-06-30 $14
2010-03-31 $14
2009-12-31 $13
2009-09-30 $12
2009-06-30 $13
2009-03-31 $12
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.800B $0.314B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Straumann Holding AG (SAUHY) Switzerland $22.515B 0.00
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47